Dow Jones U.S. Pharmaceuticals Index
D.J. US Pharmaceutical Top 10: Value Investment Strategy
|
TOP 10 Value
|
VALUEVVV
|
GROWTHVV
|
SAFETYVV
|
COMBINED
|
|
1. SciClone Pharmaceuticals (XS, US) Pharmaceuticals
|
|
1. SciClone Pharmaceuticals (XS, US) Pharmaceuticals
|
83
|
|
80
|
|
76
|
|
75
|
|
|
2. Merck & Co. (XL, US) ☀
Pharmaceuticals
|
|
2. Merck & Co. (XL, US) ☀
Pharmaceuticals
|
72
|
|
2
|
|
68
|
|
65
|
|
|
3. Heska (XS, US) Pharmaceuticals
|
|
3. Heska (XS, US) Pharmaceuticals
|
69
|
|
85
|
|
1
|
|
66
|
|
|
4. Pfizer (XL, US) Pharmaceuticals
|
|
4. Pfizer (XL, US) Pharmaceuticals
|
68
|
|
13
|
|
75
|
|
57
|
|
|
5. Impax Laboratories (S, US) Pharmaceuticals
|
|
5. Impax Laboratories (S, US) Pharmaceuticals
|
67
|
|
66
|
|
78
|
|
50
|
|
|
6. Endocyte (XS, US) Pharmaceuticals
|
|
6. Endocyte (XS, US) Pharmaceuticals
|
67
|
|
47
|
|
61
|
|
67
|
|
|
7. Sagent (XS, US) Pharmaceuticals
|
|
7. Sagent (XS, US) Pharmaceuticals
|
67
|
|
35
|
|
62
|
|
75
|
|
|
8. Assertio Therapeutics (XS, US) Pharmaceuticals
|
|
8. Assertio Therapeutics (XS, US) Pharmaceuticals
|
67
|
|
98
|
|
4
|
|
50
|
|
|
9. Medicines (S, US) Pharmaceuticals
|
|
9. Medicines (S, US) Pharmaceuticals
|
67
|
|
10
|
|
28
|
|
3
|
|
|
10. Johnson & Johnson (XL, US) ☀
Pharmaceuticals
|
|
10. Johnson & Johnson (XL, US) ☀
Pharmaceuticals
|
60
|
|
52
|
|
25
|
|
18
|
|
January 4, 2016. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)
D.J. US Pharmaceutical Top 10: Growth Investment Strategy
|
TOP 10 Growth
|
VALUEVVV
|
GROWTHVV
|
SAFETYVV
|
COMBINED
|
|
1. Lannett (S, US) Pharmaceuticals
|
|
1. Lannett (S, US) Pharmaceuticals
|
50
|
|
100
|
|
10
|
|
75
|
|
|
2. Assertio Therapeutics (XS, US) Pharmaceuticals
|
|
2. Assertio Therapeutics (XS, US) Pharmaceuticals
|
67
|
|
98
|
|
4
|
|
50
|
|
|
3. Pacira Pharma (S, US) Pharmaceuticals
|
|
3. Pacira Pharma (S, US) Pharmaceuticals
|
1
|
|
98
|
|
55
|
|
1
|
|
|
4. Akorn (M, US) Pharmaceuticals
|
|
4. Akorn (M, US) Pharmaceuticals
|
25
|
|
98
|
|
4
|
|
1
|
|
|
5. Pernix Therapeutics (XS, US) Pharmaceuticals
|
|
5. Pernix Therapeutics (XS, US) Pharmaceuticals
|
20
|
|
98
|
|
4
|
|
1
|
|
|
6. Nektar (S, US) Pharmaceuticals
|
|
6. Nektar (S, US) Pharmaceuticals
|
1
|
|
95
|
|
36
|
|
1
|
|
|
7. Prestige (M, US) Pharmaceuticals
|
|
7. Prestige (M, US) Pharmaceuticals
|
6
|
|
93
|
|
10
|
|
13
|
|
|
8. Supernus Pharma (S, US) Pharmaceuticals
|
|
8. Supernus Pharma (S, US) Pharmaceuticals
|
33
|
|
90
|
|
92
|
|
60
|
|
|
9. Heska (XS, US) Pharmaceuticals
|
|
9. Heska (XS, US) Pharmaceuticals
|
69
|
|
85
|
|
1
|
|
66
|
|
|
10. SciClone Pharmaceuticals (XS, US) Pharmaceuticals
|
|
10. SciClone Pharmaceuticals (XS, US) Pharmaceuticals
|
83
|
|
80
|
|
76
|
|
75
|
|
January 4, 2016. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)
D.J. US Pharmaceutical Top 10: Safety Investment Strategy
|
TOP 10 Safety
|
VALUEVVV
|
GROWTHVV
|
SAFETYVV
|
COMBINED
|
|
1. Vivus (XS, US) Pharmaceuticals
|
|
1. Vivus (XS, US) Pharmaceuticals
|
26
|
|
71
|
|
100
|
|
90
|
|
|
2. Bristol-Myers Squibb (XXL, US) ☀
Pharmaceuticals
|
|
2. Bristol-Myers Squibb (XXL, US) ☀
Pharmaceuticals
|
8
|
|
51
|
|
93
|
|
30
|
|
|
3. Supernus Pharma (S, US) Pharmaceuticals
|
|
3. Supernus Pharma (S, US) Pharmaceuticals
|
33
|
|
90
|
|
92
|
|
60
|
|
|
4. Impax Laboratories (S, US) Pharmaceuticals
|
|
4. Impax Laboratories (S, US) Pharmaceuticals
|
67
|
|
66
|
|
78
|
|
50
|
|
|
5. Eli Lilly (XL, US) ☀
Pharmaceuticals
|
|
5. Eli Lilly (XL, US) ☀
Pharmaceuticals
|
16
|
|
49
|
|
78
|
|
50
|
|
|
6. SciClone Pharmaceuticals (XS, US) Pharmaceuticals
|
|
6. SciClone Pharmaceuticals (XS, US) Pharmaceuticals
|
83
|
|
80
|
|
76
|
|
75
|
|
|
7. Pfizer (XL, US) Pharmaceuticals
|
|
7. Pfizer (XL, US) Pharmaceuticals
|
68
|
|
13
|
|
75
|
|
57
|
|
|
8. Merck & Co. (XL, US) ☀
Pharmaceuticals
|
|
8. Merck & Co. (XL, US) ☀
Pharmaceuticals
|
72
|
|
2
|
|
68
|
|
65
|
|
|
9. Sagent (XS, US) Pharmaceuticals
|
|
9. Sagent (XS, US) Pharmaceuticals
|
67
|
|
35
|
|
62
|
|
75
|
|
|
10. Endocyte (XS, US) Pharmaceuticals
|
|
10. Endocyte (XS, US) Pharmaceuticals
|
67
|
|
47
|
|
61
|
|
67
|
|
January 4, 2016. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)
D.J. US Pharmaceutical Top 10: Combined Investment Strategy
|
TOP 10 Combined
|
VALUEVVV
|
GROWTHVV
|
SAFETYVV
|
COMBINED
|
|
1. Vivus (XS, US) Pharmaceuticals
|
|
1. Vivus (XS, US) Pharmaceuticals
|
26
|
|
71
|
|
100
|
|
90
|
|
|
2. SciClone Pharmaceuticals (XS, US) Pharmaceuticals
|
|
2. SciClone Pharmaceuticals (XS, US) Pharmaceuticals
|
83
|
|
80
|
|
76
|
|
75
|
|
|
3. Sagent (XS, US) Pharmaceuticals
|
|
3. Sagent (XS, US) Pharmaceuticals
|
67
|
|
35
|
|
62
|
|
75
|
|
|
4. Lannett (S, US) Pharmaceuticals
|
|
4. Lannett (S, US) Pharmaceuticals
|
50
|
|
100
|
|
10
|
|
75
|
|
|
5. Endocyte (XS, US) Pharmaceuticals
|
|
5. Endocyte (XS, US) Pharmaceuticals
|
67
|
|
47
|
|
61
|
|
67
|
|
|
6. Heska (XS, US) Pharmaceuticals
|
|
6. Heska (XS, US) Pharmaceuticals
|
69
|
|
85
|
|
1
|
|
66
|
|
|
7. Merck & Co. (XL, US) ☀
Pharmaceuticals
|
|
7. Merck & Co. (XL, US) ☀
Pharmaceuticals
|
72
|
|
2
|
|
68
|
|
65
|
|
|
8. Hospira (M, US) Pharmaceuticals
|
|
8. Hospira (M, US) Pharmaceuticals
|
57
|
|
55
|
|
57
|
|
62
|
|
|
9. Supernus Pharma (S, US) Pharmaceuticals
|
|
9. Supernus Pharma (S, US) Pharmaceuticals
|
33
|
|
90
|
|
92
|
|
60
|
|
|
10. Pfizer (XL, US) Pharmaceuticals
|
|
10. Pfizer (XL, US) Pharmaceuticals
|
68
|
|
13
|
|
75
|
|
57
|
|
January 4, 2016. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)
☀ This company has a special achievement which is documented on its stock research page.
Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.
Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from January 4, 2016.
Top 10 Stock History D.J. US Pharmaceutical
